Targeting TGF-beta as a Therapy for Alzheimer's Disease

The invention includes compositions and methods for enhancing peripheral macrophage A[beta] phagocytosis activity. The invention includes inhibiting a component of TGF-[beta] signaling pathway in peripheral macrophages to promote central nervous system infiltration and beneficial cerebral A[beta] clearance. Inhibition of TGF-[beta] signaling in peripheral macrophages represents an advantageous anti-amyloid therapeutic approach for Alzheimer's disease.

Patents:
US 20,110,136,892

Inventor(s): FLAVELL RICHARD A [US]; TOWN TERRENCE C [US]

Type of Offer: Sale



« More Biotech Patents

---